Equations and Enzymes Flashcards

(36 cards)

1
Q
  • made up of many different enzymes
  • enzymes can be inhibited or induced
  • genetic variations can alter activity
  • Part of Liver Metabolism: Phase I Enzymes
A

P - 450 System

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • METABOLIZES 50% of MEDICATIONS
  • basis for many drug interactions
  • Most important enzyme of P-450 system
A

CYP3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What type of metabolism occurs when a prodrug becomes an active compound?

A

Inactive Drug to Active Metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What type of metabolism occurs when a metabolite is further metabolized?
(Heroin –> Morphine)

A

Active Drug to Active Metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What type of metabolism occurs when the drug is ready for excretion and is the most common form of drug deactivation?

A

Active Drug to Inactive Metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What type of metabolism occurs when a metabolite is then further metabolized into a toxic metabolite?
(one of the metabolites of acetaminophen is toxic)

A

Active Drug to Toxic Metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Volume of Distribution (Vd) Equation

A

Vd = (Dose) / (plasma concentration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bioavailability Equation

A

AUCₒᵣₐₗ / AUCᵢᵥ = f

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Amount of drug that is absorbed after oral administration vs. the amount of drug that is absorbed after IV administration

A

Bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bioavailability of drugs given IV

A

f = 1 (100%) because they do not undergo first pass.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rate at which a drug is cleared from the body

A

Clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clearance Equation

A

Clearance = (Rate of Drug Elimination) / (Plasma Concentration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A CONSTANT % of the DRUG IS LOST PER UNIT of TIME
90% OF DRUGS FOLLOW THIS

A

First-Order Kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Time it takes for the blood level (concentration) of a drug to fall exactly half (50%)

A

Half-life
increased concentration = increased half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Point where drug accumulation equals drug elimination

A

Steady State Concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How many half lives are needed to reach Steady State Concentration?

17
Q

Single large dose of a drug used to raise the plasma concentration to a therapeutic level more quickly than would occur through repeated smaller doses

18
Q

CONSTANT AMOUNT OF DRUG IS LOST PER UNIT OF TIME

A

Zero-Order Kinetics

19
Q

Up to 25% of all drugs are metabolized via this enzyme.
- Beta Blockers
- Opioids
- Antipsychotics

20
Q

Preference for acidic drugs
- PPI
- Antidepressants
- Antiplatelets
- Polymorphism in Asian populations

21
Q

Clinical significance in cancer and immunological treatments
- UGT1A1 & TMPT

A

Phase II Enzymes

22
Q
  • Rate limiting step in Pentos Phosphate Pathway
  • Significant source of NADPH in body
  • African and Mediterranean Populations
    Leads to Hemolysis
23
Q

Drug Induced Hypersensitivity Reaction

A

Rash due to severe skin toxicity
- Steven Johnson Syndrome (SJS)
- Toxic Epidermal Necrosis (TEN)

24
Q

Genetic component determines if sustained virology response of anti-viral medication is likely
- European populations

25
Indication: HIV Tested: All patients Test: HLA-B*5701 gene Result: if (+) do NOT use Clinical: ↑risk of serious hypersensitivity reactions - beware of combination products that contain the drug
Abacavir (Ziagen)
26
Indication: Epilepsy, neuralgias, BPD Tested: Asian patients Test: HLA-B*1502 gene Result: if (+) do NOT use Clinical: ↑risk of SJS and TEN
Carbamazepine (Tegretol)
27
Indication: HIV Tested: All patients Test: HIV Tropism with Trofile Result: Must be CCR5 (+) to use Clinical: Patients with only CCR5 can use this drug
Maraviroc (Selzentry)
28
Indication: Gout Tested: Chinese, Thai, or Korean with Renal impairment Test: HLA-B*5801 gene Result: If (+) not recommended Clinical: ↑Risk of serous dermatologic reaction - Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome
Allopurinol
29
Indication: Acute Coronary Syndrome Tested: Patients at initial treatment Test: CYP2C19 gene Poor Metabolizers = 2C19*2 or *3 Fully Functional = 2C19*1 Clinical: ↑risk of cardiovascular events
Clopidogrel (Plavix)
30
Indication: Pain or Cough Tested: Not typically tested Test: CYP2D6 gene Ultra-rapid metabolizers = 2D6*2 allele Clinical: ↑Respiratory depression
Codeine
31
Clot prevention & treatment Tested: Not typically tested Test: CYP2C9 and VKORC1 gene 2C9*2 or 2C9*3 or VKORC1 G = USE LOWER STARTING DOSE Clinical: ↑Risk of bleeding due to decreased metabolism
Warfarin (Coumadin)
32
Clinical testing is carried out in human volunteers in three formal phases of clinical trials - Institutional Review Board must approve the study - Volunteers are informed of possible risks - Chronic safety testing in animals goes on concurrently
Clinical Trials
33
20-100 healthy volunteers (do not target disease) Evaluates safety Determines dosage range Identifies adverse effects or toxicities
Phase 1
34
Studies 100-300 patients (with target disease) Determines efficacy and dose Evaluates short-term effects and risks Only 25% of drugs make it here
Phase 2
35
Tested in formulation for market Establishes and confirms safety and efficacy 2-10 years If good results --> application to FDA - Review may take months to years
Phase 3
36
Important phase that relies on you as a provider Drug has been approved to market Adverse effects reported to FDA through MedWatch program
Phase 4